[CEREBRAL ELECTRICAL ANOMALIES ACCOMPANYING THE ONSET OR CESSATION OF NEUROLEPTIC TREATMENTS].
D014150:Antipsychotic Agents; D001463:Barbiturates; D004569:Electroencephalography; D006801:Humans; D008620:Meprobamate; D008660:Metabolism; D012559:Schizophrenia; D013375:Substance Withdrawal Syndrome; D019966:Substance-Related Disorders; D014116:Toxicology; D014149:Tranquilizing Agents
D014150:Antipsychotic Agents; D001463:Barbiturates; D014149:Tranquilizing Agents; D008620:Meprobamate
BARBITURATES; DRUG ADDICTION; DRUG WITHDRAWAL SYMPTOMS; ELECTROENCEPHALOGRAPHY; MEPROBAMATE; METABOLISM; SCHIZOPHRENIA; TOXICOLOGIC REPORT; TRANQUILIZING AGENTS
ANOMALIES 'ELECTRIQUES C'ER'EBRALES ACCOMPAGNANT LE D'EBUT OU L'ARRET DE TRAITEMENTS NEUROLEPTIQUES.